Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Konum Seçiniz
  • (212) 221 18 41 Bilgi alınız
  • (212) 221 18 41 Bilgi alınız
  • Part of brands: |
Igenomix TürkiyeIgenomix Türkiye
  • Part of brands: |
  • SİZE YOL GÖSTERİYORUZ
    • Fertilite
    • Kalıtsal hastalıkları önleyin
    • Endişesiz gebelik
  • HİZMETLERİMİZ
    • Sağlık Uzmanları için
    • Hastalar için
  • TÜM EKZOM DİZİLEME (WES) VE TANI TESTLERİ
  • HAKKIMIZDA
    • Igenomix Araştırma
    • Igenomix Hakkında
  • Webinars

Primary Ciliary Dyskinesia Precision Panel – 50 genes

Primary Ciliary Dyskinesia (PCD) is a highly heterogeneous syndrome characterized by congenital impairment of mucociliary clearance (MCC). The underlying cause is a defect of cilia in the airways, making them unable to beat normally and move respiratory secretions.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Primary Ciliary Dyskinesia (PCD) is a highly heterogeneous syndrome characterized by congenital impairment of mucociliary clearance (MCC). The underlying cause is a defect of cilia in the airways, making them unable to beat normally and move respiratory secretions. This defect also has an impact in sperm flagella, generating living but immotile spermatozoa and making patients infertile. 
  • The most common defects causing this disease are found in any polypeptide within the axoneme of cilia, in proteins present in the ciliary membrane and matrix, or in proteins needed for the proper assembly of cilia. Depending on the component missing or defective, different clinical manifestations may develop, being the symptoms and disease onset dependent on the underlying genetic defect. Some mutations result in abnormal ultrastructure, while others cause abnormal function but preserved structure. Since nodal cilia are also defective in embryos, body asymmetry occurs randomly so that approximately 50 percent of the patients have situs inversus totalis. The mode of inheritance is mainly autosomal recessive. 
  • The Igenomix Primary Ciliary Dyskinesia Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.

Indication

The Igenomix Primary Ciliary Dyskinesia Precision Panel is indicated for those patients with a clinical diagnosis or suspicion presenting with or without the following manifestations: 

  • Respiratory distress 
  • Rhinosinusitis 
  • Situs inversus 
  • Frequent otitis media 
  • Fatigue and headaches 
  • Decreased fertility or infertility 

Clinical Utility

The clinical utility of this panel is:  

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of multidisciplinary treatment including pharmacological treatment in form of mucolytic agents and antibiotics to deal with frequent infections and exacerbations. Daily chest physiotherapy is commonly used to help reduce the microbial load. Surgical intervention in form of bilateral lung transplantation is also an option for patients with end-stage respiratory insufficiency. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation. 

Genes & Diseases

See all genes & diseases
GENE  OMIM DISEASES  INHERITANCE*  % GENE COVERAGE (20X)  CLINVAR**  HGMD** 
CCDC103  Primary Ciliary
Dyskinesia
 

AR 

99.92 

4 of 4  6 of 6 
CCDC39  Primary Ciliary
Dyskinesia
 

AR 

99.56 

30 of 36  48 of 52 
CCDC40  Primary Ciliary
Dyskinesia
 

AR 

98 

35 of 35  50 of 50 
CCDC65  Primary Ciliary
Dyskinesia
 

AR 

99.98 

4 of 4  3 of 3 
CCNO  Primary Ciliary
Dyskinesia
 

AR 

99.94 

19 of 19  12 of 12 
CENPF  Stromme Syndrome 

AR 

98.83 

15 of 18  10 of 12 
CFAP221  Primary Ciliary
Dyskinesia
 

– 

89.78 

–  – 
CFAP298  Primary Ciliary
Dyskinesia
 

AR 

– 

–  – 
CFAP300  Primary Ciliary
Dyskinesia
 

AR 

– 

–  – 
DNAAF1  Primary Ciliary
Dyskinesia
 

AR 

99.55 

17 of 17  36 of 37 
DNAAF11  Primary Ciliary
Dyskinesia
 

AR 

99.88 

14 of 14  21 of 21 
DNAAF2  Primary Ciliary
Dyskinesia
 

AR 

97.45 

15 of 15  7 of 8 
DNAAF3  Primary Ciliary
Dyskinesia
 

AR 

98.95 

14 of 15  13 of 14 
DNAAF4  Primary Ciliary
Dyskinesia
 

AD,AR 

99.27 

–  – 
DNAAF5  Primary Ciliary
Dyskinesia
 

AR 

89.27 

–  – 
DNAAF6  Primary Ciliary
Dyskinesia
 

X,XR,G 

99.63 

–  – 
DNAH1  Spermatogenic
Failure, Primary
Ciliary Dyskinesia
 

AR 

100 

17 of 17  58 of 58 
DNAH11  Primary Ciliary
Dyskinesia
 

AR 

99.27 

87 of 90  159 of 169 
DNAH5  Primary Ciliary
Dyskinesia,
Situs Inversus
 

AR 

100 

188 of 188  277 of 278 
DNAH8  Spermatogenic
Failure
 

AR 

99.75 

24 of 25  12 of 12 
DNAH9  Primary Ciliary
Dyskinesia
 

AR 

98.86 

7 of 7  19 of 19 
DNAI1  Kartagener
Syndrome,
Primary Ciliary
Dyskinesia
 

AR 

96.91 

20 of 20  43 of 43 
DNAI2  Primary Ciliary
Dyskinesia,
Situs Inversus
 

AR 

98.89 

25 of 25  8 of 8 
DNAJB13  Primary Ciliary
Dyskinesia
 

AR 

99.94 

2 of 2  3 of 3 
DNAL1  Primary Ciliary
Dyskinesia
 

AR 

99.43 

4 of 4  5 of 5 
DRC1  Primary Ciliary
Dyskinesia
 

AR 

100 

5 of 5  9 of 9 
FOXJ1  Primary Ciliary
Dyskinesia
 

AD 

99.69 

4 of 4  5 of 5 
GAS2L2  Primary Ciliary
Dyskinesia
 

AR 

89 

1 of 1  4 of 5 
GAS8  Primary Ciliary
Dyskinesia
 

AR 

99.98 

4 of 4  6 of 6 
HYDIN  Primary Ciliary
Dyskinesia
 

AR 

81.7 

3 of 6  45 of 63 
INVS  Nephronophthisis,
Senior-Loken
Syndrome
 

AR 

99.9 

21 of 21  38 of 38 
LRRC56  Primary Ciliary
Dyskinesia
 

AR 

99.77 

4 of 4  5 of 5 
MCIDAS  Primary Ciliary
Dyskinesia
 

AR 

99.92 

6 of 6  4 of 4 
NEK10  Primary Ciliary
Dyskinesia
 

AR 

99.95 

4 of 4  3 of 3 
NME8  Primary Ciliary
Dyskinesia
 

AR 

99.99 

1 of 1  9 of 9 
ODAD1  Primary Ciliary
Dyskinesia
 

AR 

99.68 

7 of 9  10 of 10 
ODAD2  Primary Ciliary
Dyskinesia
 

AR 

97.3 

19 of 20  26 of 28 
ODAD3  Primary Ciliary
Dyskinesia
 

AR 

95 

10 of 10  4 of 4 
ODAD4  Primary Ciliary
Dyskinesia
 

AR 

– 

–  – 
OFD1  Primary Ciliary
Dyskinesia
 

X,XR,XD,G 

98.09 

–  – 
RPGR  Primary Ciliary
Dyskinesia
 

X,XR,G 

94 

–  – 
RSPH1  Primary Ciliary
Dyskinesia
 

AR 

100 

14 of 14  10 of 10 
RSPH3  Primary Ciliary
Dyskinesia
 

AR 

99.85 

9 of 9  5 of 5 
RSPH4A  Primary Ciliary
Dyskinesia
 

AR 

99.98 

23 of 23  27 of 27 
RSPH9  Primary Ciliary
Dyskinesia
 

AR 

100 

9 of 9  13 of 13 
SPAG1  Primary Ciliary
Dyskinesia
 

AR 

94.8 

16 of 17  11 of 12 
SPEF2  Spermatogenic
Failure, Primary
Ciliary Dyskinesia
 

AR 

99.6 

6 of 7 

10 of 13 
STK36  Primary Ciliary
Dyskinesia
 

– 

100 

–  5 of 5 
TTC12  Primary Ciliary
Dyskinesia
 

AR 

99.97 

4 of 4 

– 
ZMYND10  Primary Ciliary
Dyskinesia
 

AR 

99.98 

9 of 9 

16 of 16 

* Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial; G: Gonosomal Inheritance; D: Digenic Inheritance 

** HGMD: Number of clinically relevant mutations according to HGMD

Methodology

References

See scientific referrals

Afzelius B. A. (1976). A human syndrome caused by immotile cilia. Science (New York, N.Y.), 193(4250), 317–319. https://doi.org/10.1126/science.1084576 

Noone, P. G., Leigh, M. W., Sannuti, A., Minnix, S. L., Carson, J. L., Hazucha, M., Zariwala, M. A., & Knowles, M. R. (2004). Primary ciliary dyskinesia: diagnostic and phenotypic features. American journal of respiratory and critical care medicine, 169(4), 459–467. https://doi.org/10.1164/rccm.200303-365OC 

Kuehni, C. E., Frischer, T., Strippoli, M. P., Maurer, E., Bush, A., Nielsen, K. G., Escribano, A., Lucas, J. S., Yiallouros, P., Omran, H., Eber, E., O’Callaghan, C., Snijders, D., Barbato, A., & ERS Task Force on Primary Ciliary Dyskinesia in Children (2010). Factors influencing age at diagnosis of primary ciliary dyskinesia in European children. The European respiratory journal, 36(6), 1248–1258. https://doi.org/10.1183/09031936.00001010 

Leigh, M. W., Ferkol, T. W., Davis, S. D., Lee, H. S., Rosenfeld, M., Dell, S. D., Sagel, S. D., Milla, C., Olivier, K. N., Sullivan, K. M., Zariwala, M. A., Pittman, J. E., Shapiro, A. J., Carson, J. L., Krischer, J., Hazucha, M. J., & Knowles, M. R. (2016). Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Annals of the American Thoracic Society, 13(8), 1305–1313. https://doi.org/10.1513/AnnalsATS.201511-748OC 

Ellerman, A., & Bisgaard, H. (1997). Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. The European respiratory journal, 10(10), 2376–2379. https://doi.org/10.1183/09031936.97.10102376 

Tkebuchava, T., Niederhäuser, U., Weder, W., von Segesser, L. K., Bauersfeld, U., Felix, H., Lachat, M., & Turina, M. I. (1996). Kartagener’s syndrome: clinical presentation and cardiosurgical aspects. The Annals of thoracic surgery, 62(5), 1474–1479. https://doi.org/10.1016/0003-4975(96)00493-6 

BROŞÜR

İndirin

Request Information

SİZE YOL GÖSTERİYORUZ

Fertilite

HİZMETLERİMİZ

Genetik Çözümler
Hastalar İçin

HAKKIMIZDA

Igenomix Hakkında
Bizimle Çalışın

IGENOMIX´İ TAKİP EDİN

İletişim
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Dil Seçimi

[2024] © Igenomix Gizlilik İlkesi Kalite İlkesi Yasal Not Çerez İlkeleri     Haber ve Basın   

İletişim Formu


  • SİZE YOL GÖSTERİYORUZ
    • Fertilite
    • Kalıtsal hastalıkları önleyin
    • Endişesiz gebelik
  • HİZMETLERİMİZ
    • Sağlık Uzmanları için
    • Hastalar için
  • TÜM EKZOM DİZİLEME (WES) VE TANI TESTLERİ
  • HAKKIMIZDA
    • Igenomix Araştırma
    • Igenomix Hakkında
  • Webinars
  • Konum Seçiniz
  • Kayıtlı kullanıcılar
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT